Drawing for MEDPRESCRIPTION

USPTO serial 75792314

MEDPRESCRIPTION

Reviewed by CopyMark Law Group

Reg. 2596188Status 710
Filing date
Status date
Registration date
Jul 16, 2002
Examiner
OSLICK, SCOTT
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MEDPRESCRIPTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan B. Meyer

Susan B. Meyer Gordon & Rees LLP101 West Broadway, Suite 1600San Diego, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical utilization and review services, namely, providing an analysis and evaluation of physician prescribing patterns based on drug utilization to establish alternative cost-effective drug therapies using clinically equivalent drugs, and providing pre-printed prescription pads identifying the preferred equivalent drugs for the selected physician's most commonly prescribed medications as part of the serviceSECTION 8 - CANCELLEDSep 15, 1999

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 18, 2009C8..CANCELLED SEC. 8 (6-YR)—
Mar 31, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 10, 2007CFITCASE FILE IN TICRS—
Jun 10, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 16, 2002R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Mar 13, 2002CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Mar 13, 2002IUAAUSE AMENDMENT ACCEPTED—
Mar 13, 2002AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Oct 17, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 30, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 3, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2000IUAFUSE AMENDMENT FILED—
Aug 28, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance